| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DC10-1333 |
| P724 | Internet Archive ID | pubmed-PMC3114482 |
| P932 | PMC publication ID | 3114482 |
| P698 | PubMed publication ID | 21411503 |
| P5875 | ResearchGate publication ID | 50409085 |
| P50 | author | Eva Schernhammer | Q62586412 |
| Kathrine Rugbjerg | Q63866861 | ||
| P2093 | author name string | Beate Ritz | |
| Johnni Hansen | |||
| Lene Wermuth | |||
| P2860 | cites work | Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk. | Q51827479 |
| Type 2 diabetes and the risk of Parkinson's disease. | Q53016612 | ||
| Glucose intolerance in Parkinson's disease | Q64868292 | ||
| Morbidity during hospitalization: can we predict it? | Q70345188 | ||
| The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism | Q78786045 | ||
| Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS) | Q79314633 | ||
| Vitamin D and calcium intake in relation to type 2 diabetes in women | Q82677203 | ||
| L-type calcium channel blockers and Parkinson disease in Denmark | Q30495902 | ||
| [Comparison of registration of data from the Danish Childhood Diabetes Register and The National Discharge Register]. | Q31093230 | ||
| Misunderstanding in the classification of diabetes mellitus. What's in a name? | Q33607058 | ||
| Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease | Q36667311 | ||
| Diabetes in patients with idiopathic Parkinson's disease | Q36842047 | ||
| Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease | Q36906241 | ||
| Non-motor parkinsonism | Q37082005 | ||
| Autoimmune disease and risk for Parkinson disease: a population-based case-control study. | Q37425099 | ||
| Intensive Glycemic Control and Macrovascular Disease in Type 2 Diabetes - A Report on the 44th Annual EASD Meeting, Rome, Italy, September 2008. | Q40016814 | ||
| The relationship between diabetes mellitus and Parkinson's disease | Q40701172 | ||
| Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan | Q43116679 | ||
| Diabetes mellitus and drug-induced Parkinsonism: a case-control study | Q43811303 | ||
| Mitochondrial genotypes and cytochrome b variants associated with longevity or Parkinson's disease | Q45055025 | ||
| Serum vitamin D and subsequent occurrence of type 2 diabetes | Q45356298 | ||
| Diabetes preceding Parkinson's disease onset. A case-control study. | Q46056053 | ||
| Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study | Q48598689 | ||
| Diabetes and parkinsonian signs in older persons | Q50276792 | ||
| Parkinson's disease, stroke, and related epidemiology | Q50279711 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Denmark | Q35 |
| Parkinson's disease | Q11085 | ||
| P304 | page(s) | 1102-1108 | |
| P577 | publication date | 2011-03-16 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Diabetes and the risk of developing Parkinson's disease in Denmark | |
| P478 | volume | 34 |
| Q37267127 | Activation of ATP-sensitive potassium channels enhances DMT1-mediated iron uptake in SK-N-SH cells in vitro |
| Q35728813 | Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons |
| Q92220413 | Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review |
| Q33727268 | Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study |
| Q35846489 | Astroglial pentose phosphate pathway rates in response to high-glucose environments. |
| Q47577647 | Aβ exacerbates α-synuclein-induced neurotoxicity through impaired insulin signaling in α-synuclein-overexpressed human SK-N-MC neuronal cells. |
| Q47137783 | Biological and Clinical Implications of Comorbidities in Parkinson's Disease |
| Q38075505 | Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders. |
| Q36838860 | Cardiovascular physiology in premotor Parkinson's disease: a neuroepidemiologic study |
| Q28074143 | Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease |
| Q60938765 | Could α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson's Disease and Diabetes as Well as Potential Therapies? |
| Q64917935 | Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View |
| Q26849796 | Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis |
| Q28538916 | Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies |
| Q59813447 | Divergent Effects of Metformin on an Inflammatory Model of Parkinson's Disease |
| Q58566190 | Elucidating the multi-targeted anti-amyloid activity and enhanced islet amyloid polypeptide binding of -wrapins |
| Q36995708 | Etiologic Framework for the Study of Neurodegenerative Disorders as Well as Vascular and Metabolic Comorbidities on the Grounds of Shared Epidemiologic and Biologic Features |
| Q47585241 | Exploring the Association between Statin Use and the Risk of Parkinson's Disease: A Meta-Analysis of Observational Studies. |
| Q36847424 | Gout and the risk of Parkinson's disease in Denmark |
| Q35858073 | Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases |
| Q34040844 | In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder |
| Q36194290 | Increased Risk of Dementia in Patients With Chronic Obstructive Pulmonary Disease. |
| Q37613409 | Increased risk of Parkinson disease with diabetes mellitus in a population-based study |
| Q90462428 | Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling |
| Q64906306 | Insulin and Autophagy in Neurodegeneration. |
| Q34412464 | Insulin resistance and gray matter volume in neurodegenerative disease |
| Q35202338 | Insulin resistance impairs nigrostriatal dopamine function |
| Q44177958 | Is cardiac function impaired in premotor Parkinson's disease? A retrospective cohort study |
| Q97882637 | Lipid Metabolism is the common pathologic mechanism between Type 2 Diabetes Mellitus and Parkinson's disease |
| Q55283805 | Mitochondrial Chaperones in the Brain: Safeguarding Brain Health and Metabolism? |
| Q64240263 | Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related Pathways |
| Q61800105 | Nrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological Disorders |
| Q34983826 | Parkinson's disease is related to an increased risk of ischemic stroke-a population-based propensity score-matched follow-up study |
| Q58694525 | Pioglitazone use and Parkinson's disease: a retrospective cohort study in Taiwan |
| Q90272863 | Protective effect of hydrogen sulfide on oxidative stress-induced neurodegenerative diseases |
| Q43620593 | Restless legs syndrome in end-stage renal disease: a multicenter study in Taiwan. |
| Q36891855 | Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies |
| Q35898211 | Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications. |
| Q35949729 | Role of vitamin d in Parkinson's disease |
| Q39546196 | Statin therapy prevents the onset of Parkinson disease in patients with diabetes. |
| Q37962621 | Targeting metabolic inflammation in Parkinson's disease: implications for prospective therapeutic strategies |
| Q64095568 | The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4 |
| Q93046751 | The Relevance of Insulin Action in the Dopaminergic System |
| Q57175337 | The Therapeutic Potential of Metformin in Neurodegenerative Diseases |
| Q43693957 | The association between chronic obstructive pulmonary disease and Parkinson's disease: a nationwide population-based retrospective cohort study |
| Q37622710 | The emerging role of nutrition in Parkinson's disease |
| Q30244421 | The epidemiology of Parkinson's disease: risk factors and prevention |
| Q64785443 | Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial |
Search more.